
-
Justice orders release of migrants deported to Costa Rica by Trump
-
Vietnam tycoon will not face death penalty over $27 bn fraud: lawyer
-
Vietnam abolishes death penalty for spying, anti-state activities
-
Over 80,000 people flee severe flooding in southwest China
-
AI fakes duel over Sara Duterte impeachment in Philippines
-
UK carbon emissions cut by half since 1990: experts
-
Delap off mark as Chelsea ease into Club World Cup last 16
-
UK to reintroduce nuclear weapon-capable aircraft under NATO
-
Upstart socialist stuns political veteran in NYC mayoral primary
-
China's premier warns global trade tensions 'intensifying'
-
Chelsea through to Club World Cup knockouts, Benfica beat Bayern
-
Cummins says Green 'long-term option' as Australia face new-look Windies
-
Chelsea east past Esperance and into Club World Cup last 16
-
Stocks rally as Iran-Israel ceasefire holds, oil claws back some losses
-
Trump whirlwind to test NATO summit unity
-
Israel claims victory as US intel says Iran nuclear sites not destroyed
-
Benfica beat Bayern at Club World Cup as Auckland City hold Boca
-
RFK Jr's medical panel to revisit debunked vaccine claims
-
Sean Combs trial: Takeaways from testimony
-
Messi and Miami relishing reunion with PSG and Enrique
-
At least 10 dead in Colombia landslide
-
Extreme heat, storms take toll at Club World Cup
-
France's Versailles unveils AI-powered talking statues
-
Child vaccine coverage faltering, threatening millions: study
-
Club World Cup winners team who handles weather best: Dortmund's Kovac
-
FIFA launch probe into Rudiger racism allegation
-
Trump rattles NATO allies as he descends on summit
-
Three things we learned from the first Test between England and India
-
Saint Laurent, Vuitton kick off Paris men's fashion week
-
Amateurs Auckland City hold Boca Juniors to Club World Cup draw
-
Neymar signs for six more months with Santos with an eye on World cup
-
Grok shows 'flaws' in fact-checking Israel-Iran war: study
-
Both sides in Sean Combs trial rest case, closing arguments next
-
Benfica beat Bayern to top group C
-
Trump plays deft hand with Iran-Israel ceasefire but doubts remain
-
England knew they could 'blow match apart' says Stokes after India triumph
-
Lyon appeal relegation to Ligue 2 by financial regulator
-
US intel says strikes did not destroy Iran nuclear program
-
Nearly half the US population face scorching heat wave
-
Israel's Netanyahu vows to block Iran 'nuclear weapon' as he declares victory
-
Saint Laurent kicks off Paris men's fashion week
-
Arbitrator finds NFL encouraged teams to cut veteran guarantees: reports
-
India, Poland, Hungary make spaceflight comeback with ISS mission
-
Piot, dropped by LIV Golf, to tee off at PGA Detroit event
-
US judge backs using copyrighted books to train AI
-
Russian strikes kill 19 in Ukraine region under pressure
-
Raducanu's tears of joy, Krejcikova survives match points at Eastbourne
-
Duplantis dominates at Golden Spike in Czech Republic
-
Prosecutors of Sean Combs rest their case, eyes turn to defense
-
Duckett and Root star as England beat India in thrilling 1st Test

Philips losses worse than expected in 2024
Philips on Wednesday posted worse-than-expected losses in 2024, as the Dutch medical device maker bids to turn the page on a damaging recall of faulty sleep machines.
The firm reported a net loss of 698 million euros for the full year 2024, compared to the 463-million-euro loss it posted in 2023.
Chief executive Roy Jakobs noted "double-digit declines in demand in both consumer and health systems in China" as well as "a persistently challenging macro environment" as reasons for the losses.
Analysts polled by the company were expecting a full-year loss of 65 million euros and sales of 18.0 billion euros.
Total sales for 2024 came in as forecast at 18.0 billion euros, compared to the 18.1 billion euros gained in 2023.
In November, the firm had lowered its full-year sales target, blaming a drop in demand from Chinese hospitals. That caused stocks to plunge by more than 11 percent.
Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.
Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.
In April, it announced it had reached a $1.1 billion deal to settle US lawsuits from the faulty machines.
Philips got a boost the day before the results when the French agency for medical safety said it could sell its respirators in the country again.
"We strengthened our fundamentals and resolved significant US litigation relating to the Respironics recall," said Jakobs.
Looking ahead, the firm said it expected sales growth of between one and three percent.
These results would be hit by a "mid-to high-single-digit decline in China," the company warned.
"We remain confident in our long-term plan," said Jakobs.
For the fourth quarter, Philips posted a net loss of 333 million euros on sales of 5.0 billion euros.
Analysts had forecast fourth-quarter profits of 302 million euros and sales of 5.1 billion euros.
The firm has continued to shed jobs. It employed 67,823 people at the end of 2024, compared to 69,656 at the end of 2023.
R.Shaban--SF-PST